HQ Function

Serves as AstraZeneca's Hematology R&D Center of Excellence, focusing on drug discovery and development, particularly in covalent binding technology for oncology.

Notable Features:

Located within Pivot Park, a biopharmaceutical campus offering state-of-the-art laboratory facilities, infrastructure, and a collaborative ecosystem of research-driven companies.

Work Culture:

A highly innovative, science-driven environment focused on cutting-edge research in oncology. As part of AstraZeneca, it blends the agility and entrepreneurial spirit of a biotech with the resources and global reach of a major pharmaceutical company. Strong emphasis on collaboration, scientific rigor, and translational medicine.

HQ Significance:

The birthplace and primary development site of Calquence (acalabrutinib), a significant product in AstraZeneca's oncology portfolio. It represents a key center for AstraZeneca's global efforts in discovering and developing new treatments for hematological malignancies.

Values Reflected in HQ: The headquarters and its operations reflect core values of scientific excellence, patient-centricity, innovation, and collaboration, integral to both Acerta's founding principles and AstraZeneca's global mission.

Location:

As a wholly-owned subsidiary and AstraZeneca's Hematology R&D Center of Excellence, Acerta Pharma B.V.'s direct operational footprint is primarily in Oss, Netherlands, with its historical US operational base now part of AstraZeneca's South San Francisco R&D hub. The innovations and drug candidates originating from Acerta, such as Calquence, are supported globally by AstraZeneca's extensive infrastructure for clinical development, manufacturing, regulatory affairs, and commercialization across numerous countries worldwide.

Street Address:

Kloosterstraat 9, Building RE

City:

Oss

State/Province:

Noord-Brabant

Country:

Netherlands